Consolidated Statement Of Cash Flows

ONO PHARMACEUTICAL CO., LTD. - Filing #7710975

Concept As at
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
As at
2018-03-31
2017-04-01 to
2018-03-31
As at
2017-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss)
51,539,000,000 JPY
51,539,000,000 JPY
51,679,000,000 JPY
140,000,000 JPY
50,284,000,000 JPY
50,397,000,000 JPY
113,000,000 JPY
50,284,000,000 JPY
Depreciation and amortization
10,621,000,000 JPY
9,213,000,000 JPY
Impairment losses (reversal of impairment losses)
209,000,000 JPY
306,000,000 JPY
Decrease (increase) in inventories
-1,567,000,000 JPY
-5,971,000,000 JPY
Increase (decrease) in provisions
6,333,000,000 JPY
5,611,000,000 JPY
Increase (decrease) in retirement benefit liability
378,000,000 JPY
362,000,000 JPY
Subtotal
82,081,000,000 JPY
49,114,000,000 JPY
Interest received
77,000,000 JPY
95,000,000 JPY
Dividends received
3,092,000,000 JPY
2,902,000,000 JPY
Interest paid
-27,000,000 JPY
-14,000,000 JPY
Income taxes paid
-18,449,000,000 JPY
-36,370,000,000 JPY
Net cash provided by (used in) operating activities
66,774,000,000 JPY
15,727,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-22,303,000,000 JPY
-15,620,000,000 JPY
Proceeds from sale of property, plant and equipment
11,000,000 JPY
4,663,000,000 JPY
Purchase of intangible assets
-7,299,000,000 JPY
-14,218,000,000 JPY
Other
-1,423,000,000 JPY
-269,000,000 JPY
Net cash provided by (used in) investing activities
-49,763,000,000 JPY
-34,189,000,000 JPY
Cash flows from financing activities
Net increase (decrease) in short-term borrowings
-84,000,000 JPY
58,000,000 JPY
Repayments of long-term borrowings
-361,000,000 JPY
-417,000,000 JPY
Purchase of treasury shares
-1,000,000 JPY
-38,773,000,000 JPY
Dividends paid
-21,828,000,000 JPY
-23,414,000,000 JPY
Dividends paid to non-controlling interests
-5,000,000 JPY
-3,000,000 JPY
Net cash provided by (used in) financing activities
-22,279,000,000 JPY
-62,549,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-5,268,000,000 JPY
-81,011,000,000 JPY
Cash and cash equivalents
59,981,000,000 JPY
65,273,000,000 JPY
146,323,000,000 JPY
Effect of exchange rate changes on cash and cash equivalents
-24,000,000 JPY
-40,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.